Bank of Ann Arbor’s iShares Biotechnology ETF IBB Stock Holding History

Bank of Ann Arbor’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.21K	Buy	+39	New	+$7.82K	﹤0.01%	399

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Bank of Ann Arbor's IBB Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 39 shares worth $8.21K. The stake represents ﹤0.01% of the portfolio and ranks #399 among its holdings.

907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Bank of Ann Arbor held 39 shares of iShares Biotechnology ETF worth $8.21K as of Q3 2026.
iShares Biotechnology ETF was a new Bank of Ann Arbor position in Q3 2026.
iShares Biotechnology ETF made up ﹤0.01% of Bank of Ann Arbor's portfolio in Q3 2026, its #399 holding.
907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.